Journal of Iranian Medical Council

Journal of Iranian Medical Council

Low-Dose Atropine-Triggered Atrial Fibrillation in Chlorpyrifos Plus Cypermethrin Poisoning: A Rare Case Report and Review of Literature

Document Type : Case report

Authors
1 Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran 
2 Department of Clinical Toxicology, Isfahan Clinical Toxicology Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
4 Medical Toxicology Research Center, Faculty of Medicine. Mashhad University of Medical Sciences, Mashhad, Iran  Department of Clinical Toxicology and Poisoning, Imam Reza Hospital, Faculty of Medicine. Mashhad University of Medical Sciences, Mashhad, Iran
Abstract
Abstract
Background: Poisoning with Organophosphates (OP) and/or Pyrethroids (PYR) pesticides is common. We present a rare case of OP+PYR poisoned patient who suffered from Atrial Fibrillation (AF) at the beginning of treatment by a low dose of atropine and reviewed the literature. 
Case Presentation: A 50-year-old man had ingested about 5-10 ml of a mixture of chlorpyrifos/cypermethrin.  Half an hour later, he went to the rural hospital and 2 hr later, after gastrointestinal decontamination, he was referred to the clinical toxicology department with normal vital signs except normal sinus tachycardia [Heart rate (HR)]=105. On admission, he had nausea, vomiting, diarrhea, mild sialorrhea, symmetric mid-size pupils, wet skin, and bilateral moist rales in his lungs. His cardiac rhythm changed to rapid AF (HR >140 beats/min) after treatment with 3 mg midazolam followed by 0.3 mg of atropine (0.1 mg every 1-3 min). Atropine administration was discontinued and he was treated with 0.5 mg of digoxin. 6 hr later, his arrhythmia disappeared and all cardiac and laboratory evaluations changed to normal except reduced serum cholinesterase activity.  
Conclusion: AF may be induced by Organophosphates (OP) and Pyrethroids (PYR) intoxication or during the treatment by atropine. We could not find any known risk factor (cardiac or medical issues) for AF in the current case. It may be suggested that poisoning with OP, PYR (alone or mixed) or atropine (in general or in low dose), or combination is the trigger of AF. However, AF is not life threating and can easily cure by antiarrhythmic therapy. 

Keywords

Subjects


Abstract
Background: Poisoning with Organophosphates (OP) and/or Pyrethroids (PYR) pesticides is common. We present a rare case of OP+PYR poisoned patient who suffered from Atrial Fibrillation (AF) at the beginning of treatment by a low dose of atropine and reviewed the literature. 
Case Presentation: A 50-year-old man had ingested about 5-10 ml of a mixture of chlorpyrifos/cypermethrin.  Half an hour later, he went to the rural hospital and 2 hr later, after gastrointestinal decontamination, he was referred to the clinical toxicology department with normal vital signs except normal sinus tachycardia [Heart rate (HR)]=105. On admission, he had nausea, vomiting, diarrhea, mild sialorrhea, symmetric mid-size pupils, wet skin, and bilateral moist rales in his lungs. His cardiac rhythm changed to rapid AF (HR >140 beats/min) after treatment with 3 mg midazolam followed by 0.3 mg of atropine (0.1 mg every 1-3 min). Atropine administration was discontinued and he was treated with 0.5 mg of digoxin. 6 hr later, his arrhythmia disappeared and all cardiac and laboratory evaluations changed to normal except reduced serum cholinesterase activity.  
Conclusion: AF may be induced by Organophosphates (OP) and Pyrethroids (PYR) intoxication or during the treatment by atropine. We could not find any known risk factor (cardiac or medical issues) for AF in the current case. It may be suggested that poisoning with OP, PYR (alone or mixed) or atropine (in general or in low dose), or combination is the trigger of AF. However, AF is not life threating and can easily cure by antiarrhythmic therapy. 
Keywords: Atrial fibrillation, Atropine, Cardiotoxicity, Organo-phosphates, Pyrethrins,  

Introduction
Pesticide poisoning is one of the most common causes of hospitalization in the developing countries (1) as well as Iran. Pesticide poisoning is often caused by Organophosphates (OP), carbamate, and Pyrethroids (PYR).
OP and PYR affect many organs through different mechanisms. The main mechanism of OP is inhibition of acetylcholinesterase and increasing the concentration of acetylcholine in the biological environment (2,3) that lead to cholinergic and nicotinic toxidromes (2,3). PYR acts on voltage-sensitive sodium channels and delays the closure time (4). Therefore, PYR intoxication is manifested by nausea, vomiting, tremor, paraesthesia, hypersalivation, seizures, and depressed sensorium.
Although heart is not the main target organ of PYR or OP intoxication, it is affected in some cases (5). Some evidences have reported the ECG changes, and with lower incidence, Atrial Fibrillation (AF) in OP or PYR poisoning patients (4-10). 
AF in OP poisoned patients had been reported in some other epidemiological studies, however, the information was ill-defined. Paul and Bhattacharyya (11) reported 5 cases (4.6%) of AF in 107 OP-intoxicated cases. Also, Makwana et al reported one case of AF between 50 OP-intoxicated cases, which was reverted by diltiazem injection (9). We report a rare case of OP+PYR poisoned patient who suffered from AF at the beginning of treatment by low dose of atropine. 

Case Presentation
A 50-year-old man, following a family quarrel, ingested about 5-10 ml of a mixture of chlorpyrifos /cypermethrin near 16:30 pm at home. He had a history of lower limb partial paralysis due to spinal cord injury 10 years ago, without any past medical history of cardiac disease, hypertension, or diabetes. Half an hour after pesticide ingestion, he went to the rural hospital and complained of weakness. His vital signs were as follows: Hear Rate (HR)=105 beats/min, Blood Pressure (BP)=140/100 mmHg, Respiratory Rate (RR)=19 cycles/min, Temperature (T)=37.0°C, and Oxygen Saturation (O2 sat)=89% (Table 1). Electrocardiogram (ECG) showed normal sinus tachycardia (Figure 1). He underwent gastric lavage and received 50 g activated charcoal. Then, he was treated by supportive care consisting of electrolyte solutions administration without any medication. After medical consultation with the regional clinical toxicology fellowship, the patient was referred to Korshid Hospital’s clinical toxicology department affiliated with Isfahan University of Medical Sciences (CTD-IUMS). 
The patient arrived in CTD-IUMS at 21:00 pm (4.5 hours after pesticide ingestion). On admission, he suffered from nausea, vomiting, diarrhea, and mild sialorrhea with no runny nose or lachrymation. He was lethargic [Glasgow coma scale (GCS)=14/15; E=4, V=4, and M=6], and had mild regular tachycardia (HR=90-110 beats/min) with BP=105/70 mmHg, T=37.1°C and RR=19 cycles/min. His weight was 75 kg, height was 183 cm, and BMI=22.4. On physical examination, he had symmetric mid-size pupils with normal response to light, wet skin, normal heart sounds, bilateral moist rales in lungs auscultation, and no specific smell. On ECG performed on admission in CTD-IUMS, he had normal sinus tachycardia.
Regarding some cholinergic manifestations (nausea, vomiting, diarrhea, mild sialorrhea, wet skin and bilateral moist rales in lungs auscultation), he was candidate to atropine therapy.  After cardiac monitoring, the patient received slow infusion of 3 mg midazolam in 5 min, to control the tachycardia and reduce heart rate. His HR became less than 100 beats/min (Table 1). Then, he was treated with atropine. The first dose of Atropine (0.5 mg/ml) was diluted by 4 ml of distilled water and injected to the patient gradually, 1 ml/1-2 min. After administration of 3 ml (0.3 mg of atropine), his cardiac rate raised and became irregular (HR >140) and the distinct P wave disappeared on the bedside monitor. Other vital signs were included: GCS=13-14, BP=110/76 mmHg, and RR=18 cycles/min. The administration of atropine was held, and ECG was performed. Atrial fibrillation (AF) pattern with HR >140 was found in the ECG (Figure 1). 

Table 1. The vital signs of organophosphate/pyretroid poisoned patient with atrial fibrillation

Day

Time

Event

HR

Regularity

SBP

DBP

RR

T

Sat

GCS

First day

17:00

Registration to the local hospital

105

Regular

140

100

20

37

89

14

19:00

Discharge from the local hospital

85

Regular

125

75

18

37

95

15

21:00

Registration to CTD-IUMS

110

Regular

105

70

19

37.1

92

14

21:30

After Administration Midazolam

96

Regular

110

75

16

37

94

13

22:00

After Administration Atropine

145

Irregular

112

79

18

37.1

94

13

22:45

Registration to ICU

143

Irregular

118

82

17

37.1

94

13

Second day

00:00

Start amiodarone

146

Irregular

117

76

18

37.2

96

13

1:30

-

140

Irregular

117

48

21

37.0

95

13

2:00

Start digoxin

140

Irregular

120

67

20

37.0

97

13

4:00

-

130

Irregular

120

58

21

37.0

97

13

6:00

-

106

Regular

114

76

18

37.1

99

14

7:30

-

108

Regular

106

82

15

37.5

99

15

8:00

-

102

Regular

113

82

18

37.6

99

15

10:00

-

92

Regular

109

70

19

37.5

95

15

12:00

-

95

Regular

109

80

20

37.4

92

15

14:00

-

93

Regular

132

88

23

37.3

95

15

16:00

-

95

Regular

123

83

20

37.2

99

15

18:00

-

87

Regular

120

89

21

37.0

96

15

20:00

-

85

Regular

126

91

20

36.5

97

15

22:00

-

89

Regular

120

88

21

36.6

96

15

24:00

-

91

Regular

123

86

18

36.7

97

15

Third day

2:00

-

87

Regular

131

93

18

36.8

95

15

4:00

-

91

Regular

125

89

19

36.7

96

15

6:00

-

83

Regular

118

87

20

36.8

97

15

7:30

-

91

Regular

118

82

21

-

-

-

8:00

-

82

Regular

120

70

21

37

96

15

10:00

-

83

Regular

96

56

20

36.8

94

15

12:00

-

78

Regular

111

76

19

36.8

96

15

14:00

-

75

Regular

121

80

18

36.5

94

15

16:00

-

78

Regular

121

96

17

36.5

96

15

16:30

-

96

Regular

129

85

17

-

93

-

18:00

Retuned to ward

85

Regular

133

83

18

37

-

15

21:00

-

108

Regular

122

78

20

36.8

-

15

23:30

-

104

Regular

122

76

12

-

93

-

Fourth

day

6:00

-

91

Regular

120

80

20

37

-

15

8:00

Discharge

90

Regular

127

78

18

37.1

-

15

HR= Hear Rate (Beats/min), SBP= Systolic Blood Pressure (mmHg), DBP= Diastolic Blood Pressure (mmHg), RR= Respiratory Rate (Cycles/min), T= Temperature (°C), O2 Sat = Oxygen Saturation (%), GCS = Glasgow Coma Scale.

 

Table 2. The laboratory findings of organophosphate/pyretroid poisoned patient with atrial fibrillation

Test (unit)

Day

1th

2nd

3rd

Time

21:10

2:55

04:30

10:59

4:0

5:54

pH

7.297

-

7.355

-

-

-

PCO2 (mmHg)

47.1

-

52.2

-

-

-

HCO3 (mEq/L)

22.3

-

28.4

-

-

-

Base excess

-4.3

-

1.7

-

-

-

With blood cell count (*1000/ml)

11.4

-

10.1

-

5.3

-

Neutrophils (%)

 

93.4

-

75.1

-

59.0

-

Lymphocytes (%)

 

4.5

-

13.0

-

28.1

-

Red blood cell count (*1012/µl)

4.33

-

4.28

-

4.03

-

Hemoglobin (g/dl)

17.0

-

17.2

-

16.2

-

Hematocrit (%)

 

48.1

-

47.3

-

44.8

-

Platelet count (*1000/ml)

196

-

232

-

247

-

Partial Thromboplastin Time (S)

27

-

27.7

-

28.6

-

Prothrombin Time (S)

14.2

-

14.4

-

16.1

-

International normalized ratio

1.11

-

1.13

-

1.29

-

Blood Urea Nitrogen (mg/dL)

17.6

-

16

-

10

-

Creatinine (mg/dL)

0.87

-

0.90

 

0.99

-

Aspartate transaminase (U/L)

18

-

24

-

17

-

Alanine transaminase (U/L)

17

-

17

-

14

-

Alkaline phosphatase(U/L)

398

-

367

-

302

-

Sodium (mEq/L)

 

141

-

142

-

141.5

-

Potassium (mEq/L)

 

4.1

-

4.6

-

3

-

Blood sugar (mg/dL)

136

-

147

-

89

-

Troponin I (ng/ml)

 

-

11.7

-

14.6

-

-

Serum cholinesterase (U/mL)

264

-

-

-

-

320

Creatine phosphokinase (IU/L)

64

-

-

-

-

-

Lactate Dehydrogenase (IU/L)

312

-

-

-

-

-

Triiodothyronine (ng/dL)

-

-

-

-

70

-

Thyroid stimulating hormone (IU/L)

-

-

-

-

2.5

 

 

He was transferred to the Intensive Care Unit (ICU) at 00:00 AM and was treated with amiodarone 150 mg in 20 min continued by 360 mg for 6 hours, and 5000 units of low molecular weight heparin subcutaneously every 12 hr.
At 2:00 am, a cardiologist visited the patient and reported the irregular HR >140 beats/min, BP=121/91 mmHg, O2 sat=93%, reduced first heart sound, and moist rales in both lungs. His bedside echocardiographic assessment findings were as: Left Ventricular Ejection Fraction (LVEF)=35-40%, no pericardial effusion, no systolic, and no valvular dysfunction. However, concerning his tachycardia echocardiographic, the findings were not accurate. Regarding the recommendation of the cardiologist, amiodarone was discontinued and 0.5 mg of digoxin was injected. He also received 40 mg of Furosemide which repeated 20 mg every 8 hours. About one hour later, the patient’s HR decreased (HR=130) (Table 1) and two hours later, the patient’s pulmonary crackles decreased. At 6:00 am, the patient had a normal sinus rhythm (HR=106) and no abnormal sound was auscultated on his lungs.
On the second day, he underwent echocardiography again. Echocardiographer reported: normal left ventricular size, LVEF=50-55%, normal systolic function, grade one of diastolic dysfunction, no prominent valvular abnormality and normal Pulmonary Artery Pressure (PAP=30 mmHg).
He received no atropine or pralidoxime during hospitalization. He was treated by oral hyoscine tablet 10 mg three times per day for his mild cholinergic manifestations. All laboratory findings, including troponin, were normal, except cholinesterase serum activity (Table 2). On the third day, he was returned to the clinical toxicology ward, and after 12 hours, he was discharged in good condition and suggested to visit the psychiatrist.

Table 3. The summary of organophosphates and/or pyrethroids induced atrial fibrillation cases

Authors

(y)

(ref)

Age

(Y)/sex

Agent/

rout/

Couse

Vital

sign

CTA

Signs

and

symptoms

ECG

Cardiac en-

zymes

Lab tests

Cardiac evaluation

General treatments

Anti-arrhyth-mia

Duration of AF (H)

LOS

Ustundag et al (12)

25/M

Cyper-methrin/

Inh/ACS

BP=

120/

80 mmHg

2

Nausea,

vomiting, dizziness, palpitation,

paresthesia

AF

HR= 115

-

Normal

Normal TTE

supplementary treatment

NO

12

24 hr

Ustundag et al (12)

30/M

 

 

Dic-

hlorvos/

Ing/ACS

BP=

130/

80

mmHg 

1

Hypersaliv-ation, nausea, vomiting.

No hypoxia

AF

HR= 120

Normal

Normal

Normal TTE

Gastric lavage, Active charcoal, pralidoxim =1 g

NO

6

72 hr

Topacoglu et al (19)

 

26/M

 

 

working in a carbamate production

factory

BP=

109/

66

mmHg  HR= 64

RR= 20

Sat= 97

1

Nausea,

Vomiting, Myosis, Dyspnea.

No hyperse-cretion

AF

Normal ventri-cular response,

no ST/T changes.

Normal

Normal,

ACE =mild reduced

Normal TTE

External detoxification,

supplementary treatment,

acetylsalicylic acid=300 mg

NO

24

-

Abdelnaby (7)

12/M

 

 

OP/?/

ACS

BP=

100/60

mmHg

PR= 120

 

 

Miosis,

Fascicul-

ation,

crackles in both lungs.

AF

Rapid ventri-cular response.

Normal

Normal

Normal TTE

Atropine,

Pralidoxime

direct

current cardio- version.

-

48 hr

Patel et al (8)

42/M

 

.

 

250 ml of chlor-

pyrifos/

Ing/?

BP=

150/90

mmHg

PR= 140

RR=28

Sat= 98

 

3

Dyspnea

Altered behavior,

Sialorrhea,

Vomiting,

Crackles in both lungs.

Sweating,

Garlic odour smell,

AF

Rapid ventri-cular response.

-

Normal

Normal TTE

Atropinizatio,

pralidoxim =2 g

metoprolol = 5 mg. (Not response)

then

Amiodarone = 150mg - 60mg/kg -30mg/kg

16

6 days

Maheshwari & Chaudhary (6)

40/M

 

 

OP/Ing/

ACS

BP=

110/80

mmHg

HR= 70

 

Miosis,

Crackles in both lungs.

Fascicul-ation,

 

AF

-

Normal

Normal TTE

Atropine,

Pralidoxime,

Magnesium, sulfate

NO

-

-

Mazaraki et al (20)

 

50/M

 

Lannate

/skin

contact/ACS

BP=

120/80

mmHg

HR=

145

 

2

Chest discomfort,

Palpit-

ations, Dizziness,

Mild itching

AF

Rapid ventric-ular response.

0.5 mm horizontal

ST-depres-sion in leads V4–V6.

Normal

Eosino-phils

=

800 cells/μl

Normal coronary angiogram

enoxaparin 1 mg/kg

Esmolol = 50 μg/kg/

 

6

3 days

TTE= Trans thoracic echocardiography, ACS=Accidentally, SA= Suicidal attempt Ing=Ingested Inh= Inhaled, ACE= acetylcholine esterase

BP= Blood pressure (mmHg), HR= Heart Rate (beats/min), RR= respiratory rate (Cycle/min), Sat= Oxygen saturation (%), CTA= Lag Time between contact to admission (hours), ECG= Electrocardiogram findings, AF= Atrial Fibrillation, LOS= Length Stay in hospital.

 

Discussion
We reported a rare case of AF after ingestion of 5-10 ml chlorpyrifos/cypermethrin mixture. Patient’s cardiac rhythm changed to rapid AF (HR >140 beats/min) after treatment with low dose of atropine (0.3 mg atropine, 0.1 mg every 1-3 min). No underling cardiac problem was found. The patient was treated by digoxin and discharged in a good condition.  
AF is rarely reported in OP or PYR-poisoned patients; however, the studies review and describe the cardiac manifestation of OP or PYR poisoning are not rare. The literature was searched and seven cases of pesticide-induced AF were found (Table 3). Four cases were intoxicated by OP (the exact agent of two cases were not defined), two cases by carbamate, and one case by PYR (cypermethrin). In line with our report, cypermethrin and chlorpyrifos are two agents that induced AF in reported cases (8,12). Pesticide intoxication was the only reported risk factor for AF and all the other laboratory and cardiac evaluations were unremarkable. Three cases received specific antiarrhythmic therapy. And all of them returned to normal sinus rhythm 6 to 24 hr later. In contrast to the current case, all cases had AF before starting the treatment, while in the present case, AF was triggered by atropine (Table 3). It seems that there is no difference between the AF rhythm lasting on treated and non-treated patients. 
AF is the most common arrhythmia; however, it is rare to happen in pesticide intoxication. Both tachycardia (as in the case of PYR poisoning or during atropinization) and bradycardia (as OP poisoning) could trigger AF (13). In patients who are susceptible to atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reentrant tachycardia (AVRT), AF is triggered by tachycardia (13). Bradycardia that is induced by vagus nerve stimulation, such as during sleep, also mediates AF (13). 
AF is facilitated when action potential duration is shorted by reducing the wavelength for reentry. Action potential duration in atrial cells is shorted by acetylcholine. OP increases acetylcholine levels through inhibition of acetylcholinesterase enzyme (2). American Heart Association reported that Physostigmine, a carbamate, as a acetylcholinesterase inhibitor, mediated AF by increasing the level of acetylcholine in the heart (14). Saito et al, also evaluated the incidence of AF in patients undergone intracoronary acetylcholine provocation test for assessment of vasospastic angina. They found that about 8% of the patients who received acetylcholine injection into the coronary arteries showed AF (15). It is similar to incidence of AF among OP poisoned patients reported by Paul and Bhattacharyya  (4.8%) (11). Saito et al also reported that patients with lower body mass index (BMI) are at higher risk of AF in response to acetylcholine (15) and it is much rare in obese patients. Our case had normal BMI (22.4). 
Overactivity and dysfunction of sodium channels of cardiac cell are suggested as main mechanisms of AF. However, cypermethrin is not commonly cardiotoxic; the results of animal models have been shown histologic, functional, and ECG abnormalities (4) and therefore, it can be considered as a cardiac arrhythmogenic in mammal. Cypermethrin reduced the amplitude and duration of the P wave, atrial muscles contraction forces, and induced cardiomyopathy in frog (10). Cypermethrin, as a PYR, delays the closure of voltage-sensitive sodium channels (4). The cardiac myocytes are also rich in voltage-sensitive sodium channels. Thus, cypermethrin could lengthen the duration of sodium channel opening, prolong cardiac action potential, and evoke afterdepolarizations in myocytes resulting in an increase in the variability of contractile force and potential arrhythmias. 
The current case ingested a combination of chlorpyrifos and cypermethrin pesticides and AF was reported by both of them (8, 12). Iyyadurai et al compared the patient poisoned by chlorpyrifos, cypermethrin, or combination of two pesticides and revealed their combination can induce more severe poisoning and worse outcomes (16).
Atropine is an antagonism of muscarinic receptors that enhances sinus node automaticity and atrioventricular conduction resulting in tachycardia and maybe AF. However, the sensitivity of atropine in the different structure of heart is various and this variation could lead to unpredictable and apparently paradoxical effects. Moreover, AF had been reported in patients who received atropine for relieving non-OP induced bradycardia (17). Although atropine is the main antidote of OP poisoning and the patients sometimes received a large dose of atropine for a long time (2), AF is rare in OP poisoned patients. Three of forth OP-induced AF cases reported, continues high doses of atropine administration even after AF occurrence (Table 3). Their cardiac rhythm spontaneously returned to normal (6-8). However, in the current case, atropine administration was discontinued when AF presented and no more atropine was needed to control the symptoms. The current patient developed AF after receiving low dose of atropine (about 0.3 mg). Atropine produces a biphasic effect on cardiac rate. Low dose of atropine induces bradycardia and continuous infusion of low dose atropine (about 0.12 mg) augments the parasympatomimetic effects and reduces the heart rate and raises beat-to-beat heart rate variability. The low dose atropine-induced sinus bradycardia is mediated by a central action, cholinesterase inhibition and enhancement of vagal outflow to the heart. The following hypothesis is suggested by authors: the low dose administering of atropine in the current case caused more acetylcholinesterase inhibition, which was previously inhibited by organophosphorus, and therefore might increase the amount of acetylcholine in the heart that can cause AF (15). 
It is also suggested that hypoxia may be a cause of arrhythmia in OP poisoned patients during atropine administration. Hence, oxygen therapy is recommended before atropine administration (2). The result of a cohort study showed that the hypoxia did not increase the risk of cardiac arrhythmia in OP poisoned patients (18). However, the present case was not hypoxic at any time before and during the atropine administration (Table 1). Also, none of the reviewed cases (Table 3) had hypoxia or reduced oxygen saturation. It seems that hypoxia may not be a trigger or risk factor for the patient with dysrhythmia. 
We found no known risk factor (cardiac or medical issues) associated with AF in the current case. It may be suggested that poisoning with OP, PYR (alone or mixed), atropine (in general or in low dose), or a combination of them is the trigger of AF occurrence in the patient.
The pesticides’ serum levels were not evaluated in the present study. Also, we had to rely on the patient’s self-expression about past history of heart disease.
In conclusion, AF may occur by OP and PYR intoxication or during the treatment by atropine. It is not life-threating and is self-limited or is easily cured by routine antiarrhythmic therapy.

Funding
No funding to declare.

Acknowledgement
The authors would like to thank the patient for his oral consent for the publication of his case. We would also like to thank the staff of the CTD-IUMS for their kind cooperation. The report was approved by ethical committee of Isfahan University Medical Sciences (IR.ARI.MUI.REC.1401.172).

Conflict of Interest 
All authors declare no financial/commercial conflicts of interest.

  1. References

    1. Banaye Yazdipour A, Moshiri M, Dadpour B, Sarbaz M, Heydarian Miri H, Hajebi Khaniki S, et al. The trend of top five types of poisonings in hospitalized patients based on ICD-10 in the northeast of Iran during 2012-2018: a cross-sectional study. Health Sci Rep 2022;5(3):e587. https://pubmed.ncbi.nlm.nih.gov/35509401/
    2. Moshiri M, Darchini-Maragheh E, Balali-Mood M. Advances in toxicology and medical treatment of chemical warfare nerve agents. Daru J Pharm Sc 2012;20(1):81. https://pubmed.ncbi.nlm.nih.gov/23351280/
    3. Moshiri M, Vahabzadeh M, Etemad L, Hosseinzadeh H. Failure of intravenous lipid emulsion to reduce diazinon-induced acute toxicity: a pilot study in rats. Iran J Pharmaceut Res 2013;12(4):897. https://pubmed.ncbi.nlm.nih.gov/24523769/
    4. Shilpakar O, Karki B. Cypermethrin poisoning manifesting with prolonged bradycardia: a case report. Toxicol Rep 2021;8:10-2. https://pubmed.ncbi.nlm.nih.gov/33364178/
    5. Singh H, Luni FK, Marwaha B, Ali SS, Alo M. Transient complete heart block secondary to bed bug insecticide: a case of pyrethroid cardiac toxicity. Cardiology 2016;135(3):160-3. https://pubmed.ncbi.nlm.nih.gov/27344675/
    6. Maheshwari M, Chaudhary S. Acute atrial fibrillation complicating organophosphorus poisoning. Heart Views 2017;18(3):96-9. https://pubmed.ncbi.nlm.nih.gov/29184617/
    7. Abdelnaby M. Acute atrial fibrillation induced by organophosphorus poisoning: case report. J Clin Toxicol 2018;8(1).
    8. Patel S, Mathew R, Patel R. Atrial fibrillation: a rare ECG finding in organophosphate poisoning. Mathews J Emerg Med 2022;7(2):47-9.
    9. Makwana S, Saiyad M, Makwana V. Electrocardiographic changes in organophosphate poisoning - A prospective study of 50 cases at a tertiary care center in Gujarat. J Integ Health Sci 2017;5(2):18-24. https://doi.org/10.4103/2347-6486.240240.
    10. Coşkun B, Cömelekoğlu U, Polat A, Kaymaz FF. Evaluation of the toxic effects of cypermethrin inhalation on the frog heart. Ecotoxicol Environ Saf 2004;57(2):220-5. https://pubmed.ncbi.nlm.nih.gov/14759669/
    11. Paul UK, Bhattacharyya AK. ECG manifestations in acute organophosphorus poisoning. J Indian Med Assoc 2012;110(2):98, 107-8. https://pubmed.ncbi.nlm.nih.gov/23029843/
    12. Ustundag M, Orak M, Sayhan M, Altunc? Y, Özhasenekler A. Paroxysmal atrial fibrillation after pretroid and organic phosphor intoxication. Internet J Emerg Med 2008 5(1):1-3.
    13. Altunbas G, Ercan S, Sucu M, Davutoglu V. Atrial fibrillation triggered by drug-induced bradycardia. J Atr Fibrillation 2016;9(3):1428. https://pubmed.ncbi.nlm.nih.gov/28496924/
    14. Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Leclerc J, et al. Drug-induced arrhythmias: a scientific statement from the American heart association. Circulation 2020;142(15):e214-e33. https://pubmed.ncbi.nlm.nih.gov/32929996/
    15. Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, et al. Paroxysmal atrial fibrillation during intracoronary acetylcholine provocation test. Heart Vessels 2017;32(7):902-8. https://pubmed.ncbi.nlm.nih.gov/28005169/
    16. Iyyadurai R, Peter JV, Immanuel S, Begum A, Zachariah A, Jasmine S, et al. Organophosphate-pyrethroid combination pesticides may be associated with increased toxicity in human poisoning compared to either pesticide alone. Clin Toxicol (Phila) 2014;52(5):538-41. https://pubmed.ncbi.nlm.nih.gov/24779865/
    17. Malhotra P. ESRA19-0041 Atropine induced atrial fibrillation during lower segment cesarean section in an otherwise healthy parturient: a rare event. BMJ Publishing Group Ltd; 2019.
    18. Konickx LA, Bingham K, Eddleston M. Is oxygen required before atropine administration in organophosphorus or carbamate pesticide poisoning? – A cohort study. Clin Toxicol (Phila) 2014;52(5):531-7. https://pubmed.ncbi.nlm.nih.gov/24810796/
    19. Topacoglu H, Unverir P, Erbil B, Sarikaya S. An unusual cause of atrial fibrillation: exposure to insecticides. Am J Ind Med 2007;50(1):48-9. https://pubmed.ncbi.nlm.nih.gov/17096373/
    20. Mazaraki I, Gkouias K, Almpanis G, Kounis NG, Mazarakis A. Carbamate skin contact-induced atrial fibrillation: toxicity or hypersensitivity? Int J Cardiol 2013;168(1):e11-2. https://pubmed.ncbi.nlm.nih.gov/23706324/